Contact this trialFirst, we need to learn more about you.
Synthetic Amylin Analog
Pramlintide + Insulin with Artificial Pancreas for Type 1 Diabetes
Recruiting0 awards6 criteria
Montreal, Quebec
This trial is testing whether adding pramlintide, a synthetic analog of the hormone amylin, to a closed-loop system will better normalize glucose levels in adults with Type 1 Diabetes, especially during the post-prandial period.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.